List Of Publications

1 2 3 4 9 16 24 31

J. Fucikova, J. Rakova, M. Hensler, L. Kasikova, L. Belicová, K. Hladikova, I. Truxova, P. Skapa, J. Laco, L. Pecen, I. Praznovec, M.J.Halaska, T. Brtnicky, R. Kodet, A. Fialová, J. Pineau, A. Gey, E. Tartour, A. Ryska, L. Galluzzi, R. Spisek.

TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer.

Clin Cancer Res. 2019 May 10. pii: clincanres.4175.2018. doi: 10.1158/1078-0432.CCR-18-4175. [Epub ahead of print]

A. Grohová, K. Dáňová, R. Špíšek, L. Palová-Jelínková

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Front Immunol. 2019 Feb 5;10:79. doi: 10.3389/fimmu.2019.00079. eCollection 2019.

I. Truxova, L. Kasikova, M. Hensler, P. Skapa, J. Laco, L. Pecen, L. Belicova, I. Praznovec, M.J. Halaska, T. Brtnicky, E. Salkova, L. Rob, R. Kodet, J. Goc, C. Sautes-Fridman, W.H. Fridman, A. Ryska, L.Galluzzi, R. Spisek, J. Fucikova

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.

J Immunother Cancer. 2018 Dec 4;6(1):139. doi: 10.1186/s40425-018-0446-3.
>
This website uses cookies; by continuing to use this page, you consent to their use. About cookies